Cluster analysis on the viable strategic configuration of R&D aggressiveness & funding patterns in the emerging US biotech firms

Abstract

Focusing our research on emerging pharmaceutical firms in United States, this paper aims to find the most popular strategic configuration of research and development aggressiveness and the various funding strategies. Seventy-two firms were clustered using cluster analysis and performances of clusters were measured.